VentriPoint Diagnostics Price To Sales vs. Market Capitalization
| VPT Stock | CAD 0.11 0.01 8.33% |
VentriPoint Diagnostics Price To Sales Ratio |
|
For VentriPoint Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VentriPoint Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VentriPoint Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VentriPoint Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VentriPoint Diagnostics over time as well as its relative position and ranking within its peers.
VentriPoint |
VentriPoint Diagnostics Market Capitalization vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining VentriPoint Diagnostics's current stock value. Our valuation model uses many indicators to compare VentriPoint Diagnostics value to that of its competitors to determine the firm's financial worth. VentriPoint Diagnostics is rated second in price to sales category among its peers. It is rated first in market capitalization category among its peers creating about 72,067 of Market Capitalization per Price To Sales. At this time, VentriPoint Diagnostics' Price To Sales Ratio is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VentriPoint Diagnostics' earnings, one of the primary drivers of an investment's value.VentriPoint Market Capitalization vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
VentriPoint Diagnostics |
| = | 262.77 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
VentriPoint Diagnostics |
| = | 18.94 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
VentriPoint Market Capitalization vs Competition
VentriPoint Diagnostics is rated first in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 89.37 Million. VentriPoint Diagnostics totals roughly 18.94 Million in market capitalization claiming about 21% of equities under Health Care industry.
VentriPoint Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in VentriPoint Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, VentriPoint Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of VentriPoint Diagnostics' change in net profit over the period of time. It can combine multiple indicators of VentriPoint Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 93.1 K | 80.9 K | |
| Operating Income | -4.9 M | -4.7 M | |
| Net Loss | -4.9 M | -4.6 M | |
| Income Tax Expense | 3.00 | 2.85 | |
| Income Before Tax | -4.9 M | -5.1 M | |
| Total Other Income Expense Net | 58.6 K | 55.6 K | |
| Net Loss | -4.9 M | -4.6 M | |
| Net Loss | -2.1 M | -2.2 M | |
| Net Interest Income | 10.1 K | 10.6 K | |
| Interest Income | 76.6 K | 45.4 K | |
| Change To Netincome | 658.3 K | 691.2 K | |
| Net Loss | (0.03) | (0.03) | |
| Income Quality | 0.78 | 0.71 | |
| Net Income Per E B T | 0.99 | 0.81 |
VentriPoint Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on VentriPoint Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of VentriPoint Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the VentriPoint Diagnostics' important profitability drivers and their relationship over time.
Use VentriPoint Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VentriPoint Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will appreciate offsetting losses from the drop in the long position's value.VentriPoint Diagnostics Pair Trading
VentriPoint Diagnostics Pair Trading Analysis
The ability to find closely correlated positions to VentriPoint Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VentriPoint Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VentriPoint Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VentriPoint Diagnostics to buy it.
The correlation of VentriPoint Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VentriPoint Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VentriPoint Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VentriPoint Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your VentriPoint Diagnostics position
In addition to having VentriPoint Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Size And Style ETFs Thematic Idea Now
Size And Style ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Size And Style ETFs theme has 1092 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Size And Style ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.